Sukhjit Starch Q3 FY26 Revenue Up 10% QoQ to ₹343.86 Cr; Outlook Constructive
Sukhjit Starch & Chemicals reported Q3 FY26 revenue of ₹343.86 Cr, a 10% increase QoQ. EBITDA was ₹20.17 Cr. Profit before tax rose to ₹5.34 Cr. The company expects a 15% sales increase in Q4 FY26 over Q3 FY26 with improved margins.
The results show sequential growth and a positive outlook, which is moderately impactful for investors. However, the year-on-year performance shows a decline in revenue and profit, tempering the immediate positive impact.
The company reported sequential revenue growth and provided a positive outlook for the next quarter with expected sales increase and margin improvement.
Sukhjit Starch & Chemicals Ltd has announced its unaudited financial results for the quarter and nine months ended December 31, 2025. The company reported a revenue from operations of ₹343.86 crores for Q3 FY26, marking a 10% increase from ₹312.68 crores in the previous quarter. EBITDA for the quarter stood at ₹20.17 crores, largely stable compared to ₹20.05 crores in Q2 FY26. Profit before tax was ₹5.34 crores, up from ₹4.70 crores in the prior quarter, while profit after tax was ₹4.04 crores, slightly down from ₹4.07 crores.
For the nine-month period ended December 31, 2025, revenue from operations was ₹1023.74 crores. EBITDA for the nine months was ₹60.11 crores, and profit before tax was ₹15.71 crores. The company's Managing Director, Mr. K.K. Sardana, commented on the results, highlighting healthy operational traction and firming demand across key segments. He noted that stabilizing raw material costs, particularly for maize, and consistent government initiatives are contributing to a more predictable cost environment. The company anticipates a further increase in sales by approximately 15% in Q4 FY26 over Q3 FY26, with improved margins, driven by stable raw material trends and firming product demand.
What to do with a filing like this
Sukhjit Starch & Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sukhjit Starch & Chemicals Limited. Read the original for the full detail.